First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis

Abstract Purpose Epithelioid hemangioendothelioma (EHE) represents an ultra-rare, translocated vascular sarcoma with a heterogeneous course of disease. The optimal systemic treatment for patients with advanced EHE remains unclear. We sought to evaluate the value of pazopanib (PAZ) as a first-line tr...

Full description

Bibliographic Details

Published in:	Journal of Cancer Research and Clinical Oncology
Main Authors:	Anton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, Markus Albertsmeier, Michael Hoberger, Hans Roland Dürr, Alexander Klein, Thomas Knösel, Wolfgang G. Kunz, Andreas Mock, Ada Pusztai, Michael Völkl, Michael von Bergwelt-Baildon, Lars H. Lindner, Dorit Di Gioia, Luc M. Berclaz
Format:	Article
Language:	English
Published:	Springer 2025-04-01
Subjects:	Epithelioid hemangioendothelioma Rare cancers Metastasis Pazopanib Targeted therapy
Online Access:	https://doi.org/10.1007/s00432-025-06208-8